Aspergillus, Its Sexual States and the New International Code of Nomenclature
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Allergic Bronchopulmonary Aspergillosis Revealing Asthma
CASE REPORT published: 22 June 2021 doi: 10.3389/fimmu.2021.695954 Case Report: Allergic Bronchopulmonary Aspergillosis Revealing Asthma Houda Snen 1,2*, Aicha Kallel 2,3*, Hana Blibech 1,2, Sana Jemel 2,3, Nozha Ben Salah 1,2, Sonia Marouen 3, Nadia Mehiri 1,2, Slah Belhaj 3, Bechir Louzir 1,2 and Kalthoum Kallel 2,3 1 Pulmonary Department, Hospital Mongi Slim, La Marsa, Tunisia, 2 Faculty of Medicine, Tunis El Manar University, Tunis, Tunisia, 3 Parasitology and Mycology Department, La Rabta Hospital, Tunis, Tunisia Allergic bronchopulmonary aspergillosis (ABPA) is an immunological pulmonary disorder caused by hypersensitivity to Aspergillus which colonizes the airways of patients with asthma and cystic fibrosis. Its diagnosis could be difficult in some cases due to atypical Edited by: presentations especially when there is no medical history of asthma. Treatment of ABPA is Brian Stephen Eley, frequently associated to side effects but cumulated drug toxicity due to different molecules University of Cape Town, South Africa is rarely reported. An accurate choice among the different available molecules and Reviewed by: effective on ABPA is crucial. We report a case of ABPA in a woman without a known Shivank Singh, Southern Medical University, China history of asthma. She presented an acute bronchitis with wheezing dyspnea leading to an Richard B. Moss, acute respiratory failure. She was hospitalized in the intensive care unit. The Stanford University, United States bronchoscopy revealed a complete obstruction of the left primary bronchus by a sticky *Correspondence: Houda Snen greenish material. The culture of this material isolated Aspergillus fumigatus and that of [email protected] bronchial aspiration fluid isolated Pseudomonas aeruginosa. -
Immunopathology of Aspergillus Infections in Children with Chronic Granulomatous Disease and Cystic Fibrosis
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Aberdeen University Research Archive Immunopathology of Aspergillus Infections in Children with Chronic Granulomatous Disease and Cystic Fibrosis. Adilia Warris, MD PhD MRC Centre for Medical Mycology, Aberdeen Fungal Group, Institute of Medical Sciences, University of Aberdeen, UK. Corresponding address: Medical Research Council Centre for Medical Mycology at the University of Aberdeen, Aberdeen Fungal Group, Institute of Medical Sciences, Foresterhill, AB25 2ZD, Aberdeen, UK. Phone: +44 (0)1224437596. Fax: +44 (0)1224437506. E-mail: [email protected] Acknowledgements AW is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen. Key Words: chronic granulomatous disease, cystic fibrosis, Aspergillus, aspergillosis, inflammation Abbreviated title: Aspergillus infections in CGD and CF Running head title: Aspergillus infections in CGD and CF Introduction Children with chronic granulomatous disease (CGD) and cystic fibrosis (CF) share some important clinical characteristics which are the consequence of their intrinsic susceptibility to recurrent and opportunistic infections and exaggerated inflammation. Although the clinical phenotypes of Aspergillus disease differ substantially between those two non-neutropenic patient groups, the underlying pathophysiology show remarkable commonalities with excessive inflammation being a hallmark of Aspergillus disease. The occurrence of Aspergillus infections in these two patient populations is associated with decreased quality of life and premature death. Our knowledge of the pathophysiology of Aspergillus infections is mainly derived from infections caused by a single species - Aspergillus fumigatus - in the neutropenic host. The insights obtained in this setting do not translate well to the non-neutropenic host. -
FINAL RISK ASSESSMENT for Aspergillus Niger (February 1997)
ATTACHMENT I--FINAL RISK ASSESSMENT FOR Aspergillus niger (February 1997) I. INTRODUCTION Aspergillus niger is a member of the genus Aspergillus which includes a set of fungi that are generally considered asexual, although perfect forms (forms that reproduce sexually) have been found. Aspergilli are ubiquitous in nature. They are geographically widely distributed, and have been observed in a broad range of habitats because they can colonize a wide variety of substrates. A. niger is commonly found as a saprophyte growing on dead leaves, stored grain, compost piles, and other decaying vegetation. The spores are widespread, and are often associated with organic materials and soil. History of Commercial Use and Products Subject to TSCA Jurisdiction The primary uses of A. niger are for the production of enzymes and organic acids by fermentation. While the foods, for which some of the enzymes may be used in preparation, are not subject to TSCA, these enzymes may have multiple uses, many of which are not regulated except under TSCA. Fermentations to produce these enzymes may be carried out in vessels as large as 100,000 liters (Finkelstein et al., 1989). A. niger is also used to produce organic acids such as citric acid and gluconic acid. The history of safe use for A. niger comes primarily from its use in the food industry for the production of many enzymes such as a-amylase, amyloglucosidase, cellulases, lactase, invertase, pectinases, and acid proteases (Bennett, 1985a; Ward, 1989). In addition, the annual production of citric acid by fermentation is now approximately 350,000 tons, using either A. -
Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitisation
Allergic Bronchopulmonary Aspergillosis and Severe Asthma with Fungal Sensitisation Dr Rohit Bazaz National Aspergillosis Centre, UK Manchester University NHS Foundation Trust/University of Manchester ~ ABPA -a41'1 Severe asthma wl'th funga I Siens itisat i on Subacute IA Chronic pulmonary aspergillosjs Simp 1Ie a:spe rgmoma As r§i · bronchitis I ram une dysfu net Ion Lun· damage Immu11e hypce ractivitv Figure 1 In t@rarctfo n of Aspergillus Vliith host. ABP A, aHerg tc broncho pu~ mo na my as µe rgi ~fos lis; IA, i nvas we as ?@rgiH os 5. MANCHl·.'>I ER J:-\2 I Kosmidis, Denning . Thorax 2015;70:270–277. doi:10.1136/thoraxjnl-2014-206291 Allergic Fungal Airway Disease Phenotypes I[ Asthma AAFS SAFS ABPA-S AAFS-asthma associated with fu ngaIsensitization SAFS-severe asthma with funga l sensitization ABPA-S-seropositive a llergic bronchopulmonary aspergi ll osis AB PA-CB-all ergic bronchopulmonary aspergi ll osis with central bronchiectasis Agarwal R, CurrAlfergy Asthma Rep 2011;11:403 Woolnough K et a l, Curr Opin Pulm Med 2015;21:39 9 Stanford Lucile Packard ~ Children's. Health Children's. Hospital CJ Scanford l MEDICINE Stanford MANCHl·.'>I ER J:-\2 I Aspergi 11 us Sensitisation • Skin testing/specific lgE • Surface hydroph,obins - RodA • 30% of patients with asthma • 13% p.atients with COPD • 65% patients with CF MANCHl·.'>I ER J:-\2 I Alternar1a• ABPA •· .ABPA is an exagg·erated response ofthe imm1une system1 to AspergUlus • Com1pUcatio n of asthm1a and cystic f ibrosis (rarell·y TH2 driven COPD o r no identif ied p1 rior resp1 iratory d isease) • ABPA as a comp1 Ucation of asth ma affects around 2.5% of adullts. -
<I>Aspergillus Flavus</I> and <I>Aspergillus Parasiticus</I
1395 Journal of Food Protection, Vol. 58, No. 12, Pages 1395-1404 Copyrighl©, International Association of Milk, Food and Environmental Sanitarians Aspergillus flavus and Aspergillus parasiticus: Aflatoxigenic Fungi of Concern in Foods and Feedst: A Review HASSAN GOURAMA* and LLOYD B. BULLERMAN* Department of Food Science and Technology, University of Nebraska, Lincoln, Nebraska 68583-0919 USA Downloaded from http://meridian.allenpress.com/jfp/article-pdf/58/12/1395/1665895/0362-028x-58_12_1395.pdf by guest on 02 October 2021 (MS# 91-230: Received 22 December 19911Accepted 15 May 1995) ABSTRACT isolates are still used as specific names, e.g., Aspergillus capitatus, Aspergillus niger, etc. (98). Aspergillus are com- Aspergillusflavus and the closely related subspeciesparasiticus have long been recognized as major contaminants of organic and mon saprobic molds, which grow in a wide range of natural nonorganic items. A. flavus, a common soil fungus, can infest a wide substrates and climatic conditions. Austwick (8) reported that range of agricultural products. Some A. flavus varieties produce one conidial head may produce up to 50,000 spores. Aspergil- aflatoxins, which are carcinogenic toxins that induce liver cancer in lus spp. are of particular importance to humans. Although laboratory animals. A.flavus var.flavus, A.flavus subsp. parasiticus, many Aspergillus species are considered pathogens or spoil- and A. nomius share the ability to produce aflatoxins. Identification age organisms, many others are beneficial. Some species are of the A. flavus species group is mainly based on the color and used to prepare fermented foods (57). Aspergillus spp. can macroscopic and microscopic characteristics of the fungus. -
Ergot Alkaloid Biosynthesis in Aspergillus Fumigatus : Association with Sporulation and Clustered Genes Common Among Ergot Fungi
Graduate Theses, Dissertations, and Problem Reports 2009 Ergot alkaloid biosynthesis in Aspergillus fumigatus : Association with sporulation and clustered genes common among ergot fungi Christine M. Coyle West Virginia University Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Coyle, Christine M., "Ergot alkaloid biosynthesis in Aspergillus fumigatus : Association with sporulation and clustered genes common among ergot fungi" (2009). Graduate Theses, Dissertations, and Problem Reports. 4453. https://researchrepository.wvu.edu/etd/4453 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Ergot alkaloid biosynthesis in Aspergillus fumigatus: Association with sporulation and clustered genes common among ergot fungi Christine M. Coyle Dissertation submitted to the Davis College of Agriculture, Forestry, and Consumer Sciences at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Genetics and Developmental Biology Daniel G. Panaccione, Ph.D., Chair Kenneth P. Blemings, Ph.D. Joseph B. -
The Phylogeny of Plant and Animal Pathogens in the Ascomycota
Physiological and Molecular Plant Pathology (2001) 59, 165±187 doi:10.1006/pmpp.2001.0355, available online at http://www.idealibrary.com on MINI-REVIEW The phylogeny of plant and animal pathogens in the Ascomycota MARY L. BERBEE* Department of Botany, University of British Columbia, 6270 University Blvd, Vancouver, BC V6T 1Z4, Canada (Accepted for publication August 2001) What makes a fungus pathogenic? In this review, phylogenetic inference is used to speculate on the evolution of plant and animal pathogens in the fungal Phylum Ascomycota. A phylogeny is presented using 297 18S ribosomal DNA sequences from GenBank and it is shown that most known plant pathogens are concentrated in four classes in the Ascomycota. Animal pathogens are also concentrated, but in two ascomycete classes that contain few, if any, plant pathogens. Rather than appearing as a constant character of a class, the ability to cause disease in plants and animals was gained and lost repeatedly. The genes that code for some traits involved in pathogenicity or virulence have been cloned and characterized, and so the evolutionary relationships of a few of the genes for enzymes and toxins known to play roles in diseases were explored. In general, these genes are too narrowly distributed and too recent in origin to explain the broad patterns of origin of pathogens. Co-evolution could potentially be part of an explanation for phylogenetic patterns of pathogenesis. Robust phylogenies not only of the fungi, but also of host plants and animals are becoming available, allowing for critical analysis of the nature of co-evolutionary warfare. Host animals, particularly human hosts have had little obvious eect on fungal evolution and most cases of fungal disease in humans appear to represent an evolutionary dead end for the fungus. -
Monoclonal Antibodies As Tools to Combat Fungal Infections
Journal of Fungi Review Monoclonal Antibodies as Tools to Combat Fungal Infections Sebastian Ulrich and Frank Ebel * Institute for Infectious Diseases and Zoonoses, Faculty of Veterinary Medicine, Ludwig-Maximilians-University, D-80539 Munich, Germany; [email protected] * Correspondence: [email protected] Received: 26 November 2019; Accepted: 31 January 2020; Published: 4 February 2020 Abstract: Antibodies represent an important element in the adaptive immune response and a major tool to eliminate microbial pathogens. For many bacterial and viral infections, efficient vaccines exist, but not for fungal pathogens. For a long time, antibodies have been assumed to be of minor importance for a successful clearance of fungal infections; however this perception has been challenged by a large number of studies over the last three decades. In this review, we focus on the potential therapeutic and prophylactic use of monoclonal antibodies. Since systemic mycoses normally occur in severely immunocompromised patients, a passive immunization using monoclonal antibodies is a promising approach to directly attack the fungal pathogen and/or to activate and strengthen the residual antifungal immune response in these patients. Keywords: monoclonal antibodies; invasive fungal infections; therapy; prophylaxis; opsonization 1. Introduction Fungal pathogens represent a major threat for immunocompromised individuals [1]. Mortality rates associated with deep mycoses are generally high, reflecting shortcomings in diagnostics as well as limited and often insufficient treatment options. Apart from the development of novel antifungal agents, it is a promising approach to activate antimicrobial mechanisms employed by the immune system to eliminate microbial intruders. Antibodies represent a major tool to mark and combat microbes. Moreover, monoclonal antibodies (mAbs) are highly specific reagents that opened new avenues for the treatment of cancer and other diseases. -
MM 0839 REV0 0918 Idweek 2018 Mucor Abstract Poster FINAL
Invasive Mucormycosis Management: Mucorales PCR Provides Important, Novel Diagnostic Information Kyle Wilgers,1 Joel Waddell,2 Aaron Tyler,1 J. Allyson Hays,2,3 Mark C. Wissel,1 Michelle L. Altrich,1 Steve Kleiboeker,1 Dwight E. Yin2,3 1 Viracor Eurofins Clinical Diagnostics, Lee’s Summit, MO 2 Children’s Mercy, Kansas City, MO 3 University of Missouri-Kansas City School of Medicine, Kansas City, MO INTRODUCTION RESULTS Early diagnosis and treatment of invasive mucormycosis (IM) affects patient MUC PCR results of BAL submitted for Aspergillus testing. The proportions of Case study of IM confirmed by MUC PCR. A 12 year-old boy with multiply relapsed pre- outcomes. In immunocompromised patients, timely diagnosis and initiation of appropriate samples positive for Mucorales and Aspergillus in BAL specimens submitted for IA testing B cell acute lymphoblastic leukemia, despite extensive chemotherapy, two allogeneic antifungal therapy are critical to improving survival and reducing morbidity (Chamilos et al., are compared in Table 2. Out of 869 cases, 12 (1.4%) had POS MUC PCR, of which only hematopoietic stem cell transplants, and CAR T-cell therapy, presented with febrile 2008; Kontoyiannis et al., 2014; Walsh et al., 2012). two had been ordered for MUC PCR. Aspergillus was positive in 56/869 (6.4%) of neutropenia (0 cells/mm3), cough, and right shoulder pain while on fluconazole patients, with 5/869 (0.6%) positive for Aspergillus fumigatus and 50/869 (5.8%) positive prophylaxis. Chest CT revealed a right lung cavity, which ultimately became 5.6 x 6.2 x 5.9 Differentiating diagnosis between IM and invasive aspergillosis (IA) affects patient for Aspergillus terreus. -
Allergic Bronchopulmonary Aspergillosis: a Perplexing Clinical Entity Ashok Shah,1* Chandramani Panjabi2
Review Allergy Asthma Immunol Res. 2016 July;8(4):282-297. http://dx.doi.org/10.4168/aair.2016.8.4.282 pISSN 2092-7355 • eISSN 2092-7363 Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity Ashok Shah,1* Chandramani Panjabi2 1Department of Pulmonary Medicine, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India 2Department of Respiratory Medicine, Mata Chanan Devi Hospital, New Delhi, India This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. In susceptible individuals, inhalation of Aspergillus spores can affect the respiratory tract in many ways. These spores get trapped in the viscid spu- tum of asthmatic subjects which triggers a cascade of inflammatory reactions that can result in Aspergillus-induced asthma, allergic bronchopulmo- nary aspergillosis (ABPA), and allergic Aspergillus sinusitis (AAS). An immunologically mediated disease, ABPA, occurs predominantly in patients with asthma and cystic fibrosis (CF). A set of criteria, which is still evolving, is required for diagnosis. Imaging plays a compelling role in the diagno- sis and monitoring of the disease. Demonstration of central bronchiectasis with normal tapering bronchi is still considered pathognomonic in pa- tients without CF. Elevated serum IgE levels and Aspergillus-specific IgE and/or IgG are also vital for the diagnosis. Mucoid impaction occurring in the paranasal sinuses results in AAS, which also requires a set of diagnostic criteria. Demonstration of fungal elements in sinus material is the hall- mark of AAS. -
What Threatens the Safety of Almonds?
OCTOBER 2020 ALL ABOUT ALMONDS FOOD SAFETY WHAT THREATENS FOOD SAFETY IN ALMONDS1 Chemical contamination CONTENTS Chemical contaminants include pesticide residues, allergens and mycotoxins. Aflatoxins are a specific form of mycotoxin. Pesticide residues are minimised by the correct use of registered (or permitted) Page 1: Aflatoxins - chemicals contaminants of concern chemicals. Worldwide, nut aflatoxins are of concern. Aflatoxins are natural but toxic by-products of fungi. They are odourless and Page 2: Risk reduction and prevention colourless, and cannot be visually detected in a food product. They may enter the almond food chain in the orchard, in stockpiles or in Page 4: Biological contaminant - Salmonella storage, and persist in finished, raw product. Page 5: Orchard guidelines for aflatoxin and Biological contamination Salmonella management Biological contaminants include parasites and pathogens that are usually fungal, viral, or bacterial in nature. The most important biological food safety contaminants of almonds are bacterial - Introduction Salmonella spp. and Escherichia coli (E. coli). Both are indicative of food Although almonds are not a readily perishable commodity, they are, exposure to faecal material. These organisms have serious human like other fresh foods, subject to contamination of food safety concern. health consequences, and therefore all food production and handling Almond contaminants are categorised as being chemical, biological, or management must ensure such exposure is minimised. physical in nature. Physical contamination The ‘cost’ of contaminated nuts is multi-faceted. Not only is there a Foreign matter of concern in almonds is that which is solid, and capable potential human cost in terms of health (and occasionally, life), but also of causing human injury or illness, e.g. -
Taxonomy and Evolution of Aspergillus, Penicillium and Talaromyces in the Omics Era – Past, Present and Future
Computational and Structural Biotechnology Journal 16 (2018) 197–210 Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/csbj Taxonomy and evolution of Aspergillus, Penicillium and Talaromyces in the omics era – Past, present and future Chi-Ching Tsang a, James Y.M. Tang a, Susanna K.P. Lau a,b,c,d,e,⁎, Patrick C.Y. Woo a,b,c,d,e,⁎ a Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong b Research Centre of Infection and Immunology, The University of Hong Kong, Hong Kong c State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong d Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong e Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong article info abstract Article history: Aspergillus, Penicillium and Talaromyces are diverse, phenotypically polythetic genera encompassing species im- Received 25 October 2017 portant to the environment, economy, biotechnology and medicine, causing significant social impacts. Taxo- Received in revised form 12 March 2018 nomic studies on these fungi are essential since they could provide invaluable information on their Accepted 23 May 2018 evolutionary relationships and define criteria for species recognition. With the advancement of various biological, Available online 31 May 2018 biochemical and computational technologies, different approaches have been adopted for the taxonomy of Asper- gillus, Penicillium and Talaromyces; for example, from traditional morphotyping, phenotyping to chemotyping Keywords: Aspergillus (e.g. lipotyping, proteotypingand metabolotyping) and then mitogenotyping and/or phylotyping. Since different Penicillium taxonomic approaches focus on different sets of characters of the organisms, various classification and identifica- Talaromyces tion schemes would result.